| |
| Issue |
Title |
| |
| Vol 29, No 3 (2024) |
Comparative analysis of pharmacotherapy for patients with coronary artery disease and type 2 diabetes at various healthcare stages |
Abstract
PDF (Rus)
|
|
M. A. Kokozheva, B. U. Mardanov, M. N. Mamedov |
| |
| Vol 29, No 1 (2024) |
Triple fixed-dose combination of amlodipine, indapamide and perindopril for hypertension in patients with stable coronary artery disease and abdominal obesity |
Abstract
PDF (Rus)
|
|
E. A. Polyakova, Yu. Sh. Khalimov |
| |
| Vol 29, No 1 (2024) |
Contribution of ticagrelor therapy in patients with acute coronary syndrome and patients with myocardial infarction to the achievement of State Program "Health Development" target in Russia as a whole and Russian regions in 2023-2025 |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, S. K. Zyryanov, F. N. Paleev, A. N. Yakovlev, Yu. V. Gagarina, T. V. Marin |
| |
| Vol 29, No 2 (2024) |
Changes of natriuresis and prediction of cardiovascular events in patients with type 2 diabetes and decompensated heart failure over therapy with sodium-glucose cotransporter 2 inhibitors and standard diuretic therapy |
Abstract
PDF (Rus)
|
|
O. A. Abdullaev, A. G. Arutyunov, D. P. Vereshchak, E. V. Tavlueva, V. A. Konik, N. A. Bylova, D. V. Puzenko, N. P. Kulagina, I. R. Nurieva, T. V. Zanina, G. P. Arutyunov |
| |
| Vol 28, No 6 (2023) |
Clinical and economic analysis of empagliflozin therapy in patients with heart failure across the ejection fraction range |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Lutova, E. A. Popova |
| |
| Vol 28, No 3 (2023) |
Choice of specific and anticoagulant therapy in patients with newly diagnosed chronic thromboembolic pulmonary hypertension, depending on operability status |
Abstract
PDF (Rus)
|
|
Z. S. Valieva, T. V. Martynyuk |
| |
| Vol 28, No 3 (2023) |
Сost-effectiveness of preventing cardiovascular death and achieving the target indicator "Reduction of the cardiovascular mortality of the population" of the State Program "Health Development" when using valsartan+sacubitril, dapagliflozin and empagliflozin in patients with heart failure with reduced ejection fraction |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, S. N. Tereshchenko, I. V. Zhirov, S. V. Nedogoda, Yu. V. Gagarina, E. A. Shabalina |
| |
| 1 - 7 of 7 Items |
|
